The present invention relates to novel quinolones of Formula I that
inhibit inducible NOS synthase together with methods of synthesizing and
using the compounds including methods for inhibiting or modulating nitric
oxide synthesis and/or lowering nitric oxide levels in a patient by
administering the compounds for the treatment of disease.